Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KISSEI PHARMA shares extend gains as major domestic brokerage initiates coverage with top rating
KISSEI PHARMACEUTICAL CO.,LTD. <4547> extended its gains. SMBC Nikko Securities initiated coverage on the company's shares on the 1st with a top rating of "1" on its three-tier scale. The target price was set at \5,500. The brokerage cited the following factors for its positive rating: (1) stable growth is expected through the fiscal year ending March 2032, driven by growth in its core rare disease pipeline; (2) the company's proprietary new drugs, including uterine fibroid treatment "linzagolix" and Parkinson's disease treatment "matsupexole," are beginning to emerge, with expectations for improved performance through overseas expansion; and (3) improvements in capital efficiency and support for the share price from high dividend yields.
Source: MINKABU PRESS
Related Articles
BULL-DOG SAUCE extends gains on expected investment securities sale gain
KOBAYASHI YOKO expands gains in afternoon session on higher commodity and financial product trading volumes in March
Birdman Ranks 3rd in Rising Buy Predictions Among Individual Investors: Minkabu Survey
CocaCola Bottlers Japan shares plunge as domestic brokerage downgrades on valuation concerns
Ekitan & Co.,Ltd. Rises on Launch of AI-DX Project Team with IP DREAM
H2O RETAILING extends gains on return to positive sales growth in March
Kioxia Holdings Tops "Rising Buy Predictions" Ranking Among Individual Investors: Minkabu Survey
Mitsubishi HC Capital extends gains after foreign brokerage initiates coverage with Overweight rating
Howa Machinery extends gains on subsidiary acquisition of street sweeper leasing firm Machine Serviceâ—‡
DIGITAL PLUS gains momentum in afternoon session on 30% quarterly increase in fintech business transaction volume for Jan-Mar